Keros Therapeutics, Inc.KROSNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank86
3Y CAGR+28.1%
5Y CAGR+80.1%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+28.1%/yr
vs +101.5%/yr prior
5Y CAGR
+80.1%/yr
Recent deceleration
Acceleration
-73.4pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
18.9x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $21.27M | -10.5% |
| 2024 | $23.78M | +40.3% |
| 2023 | $16.95M | +67.6% |
| 2022 | $10.11M | +2908.6% |
| 2021 | $-360000.00 | -132.0% |
| 2020 | $1.12M | +163.4% |
| 2019 | $-1.77M | -389.2% |
| 2018 | $613000.00 | - |